Mixed

The RECODe risk equations provide more accurate predictions for microvascular and cardiovascular complications in diverse U.S. populations with type 2 diabetes compared to older models like UKPDS OM2 and ACC/AHA PCEs, which tend to substantially overestimate risk.

For clinicians managing diverse type 2 diabetes patients, using the RECODe risk equations instead of older models (like UKPDS or ACC/AHA PCEs) leads to more accurate risk assessment. This accuracy helps avoid unnecessary aggressive treatments for patients at lower actual risk and ensures high-risk patients receive appropriate intensive care, thereby reducing drug-related morbidity and improving overall population health management.